Few & Far Between: How Biotech Gets Built

Episode 29: Mika Newton, CEO at XCures


Listen Later

"We work with hundreds of patients a month, helping them understand their own medical history and then tracking what happens to them in the future and providing them and their physicians with decision support and alternative thinking about ways to treat their cancer." Mika Newton, CEO at xCures

Biorasi welcomes Mika Newton to the Few & Far Between podcast to examine how the connection between AI and oncology leads to a more patient-centric world.

...more
View all episodesView all episodes
Download on the App Store

Few & Far Between: How Biotech Gets BuiltBy Chris O'Brien

  • 5
  • 5
  • 5
  • 5
  • 5

5

15 ratings